Patient Guide: A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 2 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07739186
Status: UPCOMING
Condition: Non-squamous Non-small Cell Lung Cancer
Phase: Phase II, Phase III

Find a Study Location Near You

This study is available at 2 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Guangzhou, Guangdong
  • Guangzhou, Guangdong

Loading interactive enrollment tools...

The full interactive experience will load momentarily